Biotech Sector Faces FDA Turmoil
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 11 2026
0mins
Source: Fool
- FDA Chaos Impacts Approvals: The biotech sector had a strong performance in 2025, with the XBI index outperforming NVIDIA, yet ongoing chaos at the FDA may lead to longer drug approval cycles, increasing investment risks and affecting industry confidence.
- Executive Warns of Industry Risks: Former FDA oncology head Richard Pasdur warned at the JP Morgan conference that the breach between political appointees and drug reviewers could lead to inconsistent approval standards, creating uncertainty for biotech companies.
- Gene Therapy Approval Delays: Regenxbio's expected approval for a Hunter syndrome drug on February 8 is now unlikely due to a tumor found in a patient during clinical trials, indicating stricter FDA oversight on gene therapies and prompting investor caution.
- Twist Bioscience Shows Recovery: Twist Bioscience reported $104 million in revenue for Q1, despite remaining unprofitable, but reduced cash burn indicates a sustainable growth trend, attracting investor interest amid the biotech downturn.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVDA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise
41 Analyst Rating
39 Buy
1 Hold
1 Sell
Strong Buy
Current: 214.250
Low
200.00
Averages
264.97
High
352.00
Current: 214.250
Low
200.00
Averages
264.97
High
352.00
About NVDA
NVIDIA Corporation is an artificial intelligence (AI) infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. Its segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing and networking platforms and AI solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment includes GeForce GPUs for gaming and personal computers (PCs), and Quadro/NVIDIA RTX GPUs for enterprise workstation graphics. Its technology stack includes the foundational NVIDIA CUDA development platform that runs on all NVIDIA GPUs, as well as hundreds of domain-specific software libraries, frameworks, algorithms, software development kits (SDKs), and application programming interfaces (APIs). Its platforms address four markets, which include Data Center, Gaming, Professional Visualization, and Automotive.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strong Earnings Report: Nvidia's fiscal Q1 2027 revenue reached $81.6 billion, an 85% year-over-year increase, reflecting robust market demand and business acceleration, particularly in its AI-driven data center segment, which saw a 92% revenue growth, laying a solid foundation for future growth.
- Significant Profit Increase: Non-GAAP earnings per share surged 140% year-over-year to $1.87, driven by revenue growth and margin expansion, indicating a substantial enhancement in the company's profitability within the AI sector, further solidifying its market leadership.
- Aggressive Capital Return: Nvidia raised its quarterly dividend from $0.01 to $0.25, a 25-fold increase, and authorized an $80 billion share repurchase plan, demonstrating strong confidence in future cash flows while returning approximately $20 billion to shareholders in the last quarter alone.
- Forward-Looking Commitments: Management anticipates about $1 trillion in revenue visibility from 2025 to 2027, with total supply commitments swelling to $145 billion, indicating a long-term bullish outlook on the AI market, despite competitive risks from customers developing their own custom chips.
See More
- Successful Oxychem Acquisition: Berkshire Hathaway's $9.7 billion acquisition of Oxychem was finalized during a downturn in the chemical industry, with an estimated 8x EBITDA for 2025, benefiting from modernization efforts and pricing power, leading to excellent first-quarter performance.
- Strategic Tokio Marine Investment: Abel's $1.8 billion purchase of a 2.5% stake in Tokio Marine, with permission to increase to 9.9%, was made at a premium of nearly twice book value, yet is expected to yield additional upside through a risk-sharing agreement, enhancing the insurance business.
- Precise Timing in Alphabet Investment: Abel tripled Berkshire's stake in Alphabet to $22.5 billion, investing approximately $11 billion in the first quarter, capitalizing on market recovery and strong AI-driven earnings, with the stock price rising about 35% since last quarter.
- AI-Driven Revenue Growth: Alphabet's cloud revenue surged 63%, with operating margins expanding from 17.8% to 32.9%, as AI integration improved search and advertising performance, resulting in a 19% increase in search revenue, indicating strong future growth potential.
See More
- Strategic Partnership: Iren's agreement with Nvidia to deploy AI chips for up to 5 gigawatts in its data centers is set to accelerate revenue growth and enhance market competitiveness for Iren.
- Equity Investment Opportunity: Nvidia has the right to purchase up to 30 million shares of Iren at $70 each over the next five years, potentially representing a $2.1 billion investment that further solidifies the partnership.
- Cloud Customer Relationship: The five-year agreement for 60 megawatts of existing capacity with Nvidia, valued at $3.4 billion, is expected to generate $680 million annually for Iren, significantly boosting its financial performance.
- Revenue Forecast Adjustment: Following the Nvidia deal, Iren raised its annualized revenue run rate from $3.7 billion to $4.4 billion, reflecting strong confidence in future growth and creating greater value for shareholders.
See More
- Strategic Partnership: Iren's agreement with Nvidia enables the deployment of AI chips for up to 5 gigawatts in its data centers, significantly enhancing Iren's revenue potential and solidifying its leadership in the data center market.
- Equity Investment Opportunity: Nvidia has the right to purchase up to 30 million shares of Iren at $70 each over the next five years, which could amount to a $2.1 billion investment, further strengthening the strategic relationship between the two companies.
- Annual Revenue Increase: Iren raised its annual revenue run rate from $3.7 billion to $4.4 billion due to the partnership with Nvidia, indicating strong growth potential in the AI market while also providing Nvidia with increased chip sales opportunities.
- Expanded Customer Base: Iren signed a five-year agreement with Nvidia for 60 megawatts of existing capacity valued at $3.4 billion, further solidifying Iren's position in the AI cloud services market and laying the groundwork for future business growth.
See More
- Institutional Inflows: In May 2026, Solana spot ETFs recorded $115.34 million in monthly inflows with zero outflow days, reflecting strong institutional confidence in Solana, especially as Bitcoin and Ethereum ETFs faced significant outflows during the same period.
- On-Chain Activity Growth: Solana outperformed Ethereum in DEX volume at $36.87 billion, capturing 32.6% of global stablecoin transfers, indicating a growing preference for Solana in real economic transactions, which further solidifies its market position.
- Catalytic Upgrade: The upcoming Alpenglow upgrade aims to reduce transaction finality from 12.8 seconds to 150 milliseconds, which is expected to significantly enhance Solana's transaction efficiency, attracting more users and developers and potentially driving SOL prices higher.
- Market Competition Risks: Despite strong ETF inflows, a 30% drop in futures market open interest indicates caution among speculators, while selling pressure from Pump.fun poses a challenge to SOL's ability to break above the $90 resistance level.
See More
- SpaceX IPO Outlook: SpaceX is set to debut its IPO within two weeks, targeting a valuation of $1.8 trillion, although this ambitious goal may lead to market chaos and uncertainty.
- OpenAI's Funding Needs: OpenAI is preparing a confidential filing and is expected to be the next public company due to its urgent need for capital to address significant losses, which may risk a valuation downgrade.
- Anthropic's Profitability: Anthropic has achieved an annual revenue run rate of $47 billion and is on track to turn an operating profit this quarter, making it a potential focal point for investors if it becomes the third to go public.
- Market Volatility Risks: The IPOs of SpaceX and the other two companies could strain market liquidity, likely impacting major tech stocks like Nvidia and Apple, prompting investors to navigate potential price fluctuations carefully.
See More











